SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Beryl Drugs - Quaterly Results

09 Aug 2022 Evaluate
The revenue zoomed 6.88% to Rs. 49.68 millions for the quarter ended June 2022 as compared to Rs. 46.48 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 2.17 millions from Rs. 3.39 millions, a decline of -35.99% on QoQ basis.A decline of 5.94 millions was observed in the OP in the quarter ended June 2022 from 7.08 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 49.68 46.48 6.88 49.68 46.48 6.88 147.69 142.80 3.42
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 5.94 7.08 -16.10 5.94 7.08 -16.10 5.73 16.36 -64.98
Interest 1.26 1.11 13.51 1.26 1.11 13.51 4.37 4.66 -6.22
PBDT 4.68 5.97 -21.61 4.68 5.97 -21.61 1.36 16.22 -91.62
Depreciation 2.47 2.99 -17.39 2.47 2.99 -17.39 10.86 12.73 -14.69
PBT 2.21 2.98 -25.84 2.21 2.98 -25.84 -9.50 3.49 -372.21
TAX 0.04 -0.41 -109.76 0.04 -0.41 -109.76 -2.91 1.08 -369.44
Deferred Tax 0.04 -0.41 -109.76 0.04 -0.41 -109.76 -3.00 1.08 -377.78
PAT 2.17 3.39 -35.99 2.17 3.39 -35.99 -6.59 2.41 -373.44
Equity 50.72 50.72 0.00 50.72 50.72 0.00 50.72 50.72 0.00
PBIDTM(%) 11.96 15.23 -21.51 11.96 15.23 -21.51 3.88 11.46 -66.13

Beryl Drugs Share Price

25.46 0.94 (3.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×